Habib Joseph Dable's Insider Trades & SAST Disclosures
Habib Joseph Dable's most recent trade in PepGen Inc was a trade of 13,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Habib Joseph Dable.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PepGen Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 4,570 | 4,570 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,242 | 8,742 (0%) | 0% | 0 | Common Stock | |
| Jade Biosciences Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharmaceuticals... | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Jade Biosciences Inc | Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,531 | 1,531 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges